Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone
US-2026097013-A1 · Apr 9, 2026 · US
Epicentrx Inc holds 77 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 77 |
| Recent patents | 32 |
| First publication | Jan 6, 2015 |
| Latest publication | Apr 9, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026097013-A1 · Apr 9, 2026 · US
US-2026035346-A1 · Feb 5, 2026 · US
US-2025388930-A1 · Dec 25, 2025 · US
US-2025288555-A1 · Sep 18, 2025 · US
US-12357608-B2 · Jul 15, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026097013-A1 · Apr 9, 2026 · US
US-2026035346-A1 · Feb 5, 2026 · US
US-2025388930-A1 · Dec 25, 2025 · US
US-2025288555-A1 · Sep 18, 2025 · US
US-12357608-B2 · Jul 15, 2025 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P35/00 | 51 |
| A61K31/397 | 41 |
| A61K9/0019 | 33 |
| A61P35/02 | 32 |
| A61K45/06 | 27 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 73 |
| Chemistry & Metallurgy | 42 |
| Cross-Sectional Technologies | 13 |
Answers are generated from the same data shown on this page.